"Aber" Brierling Respiratory Fusion Virus Antigen Diagnostic Reagent (Non-sterilized) - Taiwan Registration e48dc0b4a344c4350fa0c8541a04bb7d
Access comprehensive regulatory information for "Aber" Brierling Respiratory Fusion Virus Antigen Diagnostic Reagent (Non-sterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number e48dc0b4a344c4350fa0c8541a04bb7d and manufactured by Abbott Diagnostics Korea Inc.. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
e48dc0b4a344c4350fa0c8541a04bb7d
DHA09402331400
Product Details
Limited to the classification and grading management of medical devices, the first level identification range of "respiratory fusion cell virus serum reagent (C.3480)".
C Immunology and microbiology
C.3480 ๅผๅธ้่ๅ็ดฐ่็ ๆฏ่กๆธ ่ฉฆๅ
Input;; QMS/QSD
Dates and Status
Nov 21, 2023
Nov 21, 2028

